COPD Clinical Trials in California

24 recruiting studies across 6 cities

Browse by City

Los Angeles

All Trials in California

Phase

Trial	Phase	Sponsor	Dist.
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease	Phase 3	AstraZeneca	<1 mi
A Study to Evaluate Solrikitug in Participants With COPD (ZION)	Phase 2	Uniquity One (UNI)	<1 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)	Phase 3	AstraZeneca	<1 mi
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease	Phase 2	AstraZeneca	<1 mi
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD	Phase 2	Verona Pharma plc	<1 mi
SPIROMICS Study of Early COPD Progression (SOURCE)	—	University of Massachusetts, Worcester	<1 mi
Multi-Center Clean Air Randomized Controlled Trial in COPD	Phase 3	JHSPH Center for Clinical Trials	<1 mi
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening	—	Freenome Holdings Inc.	<1 mi
PiMZ Longitudinal Cohort (PiMZ Logic)	—	Columbia University	<1 mi
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3	N/A	Apreo Health, Inc.	<1 mi
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD	Phase 2	Johns Hopkins University	<1 mi
The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)	Phase 4	University of California, San Francisco	<1 mi
Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD	N/A	University of California, San Francisco	<1 mi
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD	Phase 2	Upstream Bio Inc.	<1 mi
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)	Phase 3	Hoffmann-La Roche	<1 mi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype	Phase 3	Sanofi	<1 mi
Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap	—	Gelb, Arthur F., M.D.	7 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)	Phase 3	AstraZeneca	10 mi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype	Phase 3	Sanofi	10 mi
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)	Phase 2	University of California, San Diego	11 mi
STRIVE Post-Market Registry Study	—	Olympus Corporation of the Americas	11 mi
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease	Phase 3	Hoffmann-La Roche	16 mi
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease	Phase 1	Genentech, Inc.	16 mi
Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)	Phase 2	Connect Biopharm LLC	34 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.